Pretest probability for patients with suspected obstructive coronary artery disease

re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial

Borek Foldyna, James E. Udelson, Júlia Karády, Dahlia Banerji, Michael T. Lu, Thomas Mayrhofer, Daniel O. Bittner, Nandini M. Meyersohn, Hamed Emami, Tessa S.S. Genders, Christopher B. Fordyce, Maros Ferencik, Pamela S. Douglas, Udo Hoffmann

    Research output: Contribution to journalArticle

    2 Citations (Scopus)

    Abstract

    AIMS: To update pretest probabilities (PTP) for obstructive coronary artery disease (CAD ≥ 50%) across age, sex, and clinical symptom strata, using coronary computed tomography angiography (CTA) in a large contemporary population of patients with stable chest pain referred to non-invasive testing. METHODS AND RESULTS: We included patients enrolled in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial and randomized to CTA. Exclusively level III-certified readers, blinded to demographic and clinical data, assessed the prevalence of CAD ≥ 50% in a central core lab. After comparing the recent European Society of Cardiology-Diamond and Forrester PTP (ESC-DF) with the actual observed prevalence of CAD ≥ 50%, we created a new PTP set by replacing the ESC-DF PTP with the observed prevalence of CAD ≥ 50% across strata of age, sex, and type of angina. In 4415 patients (48.3% men; 60.5 ± 8.2 years; 78% atypical angina; 11% typical angina; 11% non-anginal chest pain), the observed prevalence of CAD ≥ 50% was 13.9%, only one-third of the average ESC-DF PTP (40.6; P < 0.001 for difference). The PTP in the new set ranged 2-48% and were consistently lower than the ESC-DF PTP across all age, sex, and angina type categories. Initially, 4284/4415 (97%) patients were classified as intermediate-probability by the ESC-DF (PTP 15-85%); using the PROMISE-PTP, 50.2% of these patients were reclassified to the low PTP category (PTP < 15%). CONCLUSION: The ESC-DF PTP overestimate vastly the actual prevalence of CAD ≥ 50%. A new set of PTP, derived from results of non-invasive testing, may substantially reduce the need for non-invasive tests in stable chest pain.

    Original languageEnglish (US)
    Pages (from-to)574-581
    Number of pages8
    JournalEuropean heart journal cardiovascular Imaging
    Volume20
    Issue number5
    DOIs
    StatePublished - May 1 2019

    Fingerprint

    Diamond
    Chest Pain
    Multicenter Studies
    Coronary Artery Disease
    Cardiology

    Keywords

    • computed tomography angiography
    • coronary stenosis
    • Diamond and Forrester
    • obstructive coronary artery disease
    • stable chest pain

    ASJC Scopus subject areas

    • Radiology Nuclear Medicine and imaging
    • Cardiology and Cardiovascular Medicine

    Cite this

    Pretest probability for patients with suspected obstructive coronary artery disease : re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial. / Foldyna, Borek; Udelson, James E.; Karády, Júlia; Banerji, Dahlia; Lu, Michael T.; Mayrhofer, Thomas; Bittner, Daniel O.; Meyersohn, Nandini M.; Emami, Hamed; Genders, Tessa S.S.; Fordyce, Christopher B.; Ferencik, Maros; Douglas, Pamela S.; Hoffmann, Udo.

    In: European heart journal cardiovascular Imaging, Vol. 20, No. 5, 01.05.2019, p. 574-581.

    Research output: Contribution to journalArticle

    Foldyna, B, Udelson, JE, Karády, J, Banerji, D, Lu, MT, Mayrhofer, T, Bittner, DO, Meyersohn, NM, Emami, H, Genders, TSS, Fordyce, CB, Ferencik, M, Douglas, PS & Hoffmann, U 2019, 'Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial', European heart journal cardiovascular Imaging, vol. 20, no. 5, pp. 574-581. https://doi.org/10.1093/ehjci/jey182
    Foldyna, Borek ; Udelson, James E. ; Karády, Júlia ; Banerji, Dahlia ; Lu, Michael T. ; Mayrhofer, Thomas ; Bittner, Daniel O. ; Meyersohn, Nandini M. ; Emami, Hamed ; Genders, Tessa S.S. ; Fordyce, Christopher B. ; Ferencik, Maros ; Douglas, Pamela S. ; Hoffmann, Udo. / Pretest probability for patients with suspected obstructive coronary artery disease : re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial. In: European heart journal cardiovascular Imaging. 2019 ; Vol. 20, No. 5. pp. 574-581.
    @article{39f5690c8ee146b4b491ee014f66ca15,
    title = "Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial",
    abstract = "AIMS: To update pretest probabilities (PTP) for obstructive coronary artery disease (CAD ≥ 50{\%}) across age, sex, and clinical symptom strata, using coronary computed tomography angiography (CTA) in a large contemporary population of patients with stable chest pain referred to non-invasive testing. METHODS AND RESULTS: We included patients enrolled in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial and randomized to CTA. Exclusively level III-certified readers, blinded to demographic and clinical data, assessed the prevalence of CAD ≥ 50{\%} in a central core lab. After comparing the recent European Society of Cardiology-Diamond and Forrester PTP (ESC-DF) with the actual observed prevalence of CAD ≥ 50{\%}, we created a new PTP set by replacing the ESC-DF PTP with the observed prevalence of CAD ≥ 50{\%} across strata of age, sex, and type of angina. In 4415 patients (48.3{\%} men; 60.5 ± 8.2 years; 78{\%} atypical angina; 11{\%} typical angina; 11{\%} non-anginal chest pain), the observed prevalence of CAD ≥ 50{\%} was 13.9{\%}, only one-third of the average ESC-DF PTP (40.6; P < 0.001 for difference). The PTP in the new set ranged 2-48{\%} and were consistently lower than the ESC-DF PTP across all age, sex, and angina type categories. Initially, 4284/4415 (97{\%}) patients were classified as intermediate-probability by the ESC-DF (PTP 15-85{\%}); using the PROMISE-PTP, 50.2{\%} of these patients were reclassified to the low PTP category (PTP < 15{\%}). CONCLUSION: The ESC-DF PTP overestimate vastly the actual prevalence of CAD ≥ 50{\%}. A new set of PTP, derived from results of non-invasive testing, may substantially reduce the need for non-invasive tests in stable chest pain.",
    keywords = "computed tomography angiography, coronary stenosis, Diamond and Forrester, obstructive coronary artery disease, stable chest pain",
    author = "Borek Foldyna and Udelson, {James E.} and J{\'u}lia Kar{\'a}dy and Dahlia Banerji and Lu, {Michael T.} and Thomas Mayrhofer and Bittner, {Daniel O.} and Meyersohn, {Nandini M.} and Hamed Emami and Genders, {Tessa S.S.} and Fordyce, {Christopher B.} and Maros Ferencik and Douglas, {Pamela S.} and Udo Hoffmann",
    year = "2019",
    month = "5",
    day = "1",
    doi = "10.1093/ehjci/jey182",
    language = "English (US)",
    volume = "20",
    pages = "574--581",
    journal = "European Heart Journal Cardiovascular Imaging",
    issn = "2047-2404",
    publisher = "Oxford University Press",
    number = "5",

    }

    TY - JOUR

    T1 - Pretest probability for patients with suspected obstructive coronary artery disease

    T2 - re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial

    AU - Foldyna, Borek

    AU - Udelson, James E.

    AU - Karády, Júlia

    AU - Banerji, Dahlia

    AU - Lu, Michael T.

    AU - Mayrhofer, Thomas

    AU - Bittner, Daniel O.

    AU - Meyersohn, Nandini M.

    AU - Emami, Hamed

    AU - Genders, Tessa S.S.

    AU - Fordyce, Christopher B.

    AU - Ferencik, Maros

    AU - Douglas, Pamela S.

    AU - Hoffmann, Udo

    PY - 2019/5/1

    Y1 - 2019/5/1

    N2 - AIMS: To update pretest probabilities (PTP) for obstructive coronary artery disease (CAD ≥ 50%) across age, sex, and clinical symptom strata, using coronary computed tomography angiography (CTA) in a large contemporary population of patients with stable chest pain referred to non-invasive testing. METHODS AND RESULTS: We included patients enrolled in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial and randomized to CTA. Exclusively level III-certified readers, blinded to demographic and clinical data, assessed the prevalence of CAD ≥ 50% in a central core lab. After comparing the recent European Society of Cardiology-Diamond and Forrester PTP (ESC-DF) with the actual observed prevalence of CAD ≥ 50%, we created a new PTP set by replacing the ESC-DF PTP with the observed prevalence of CAD ≥ 50% across strata of age, sex, and type of angina. In 4415 patients (48.3% men; 60.5 ± 8.2 years; 78% atypical angina; 11% typical angina; 11% non-anginal chest pain), the observed prevalence of CAD ≥ 50% was 13.9%, only one-third of the average ESC-DF PTP (40.6; P < 0.001 for difference). The PTP in the new set ranged 2-48% and were consistently lower than the ESC-DF PTP across all age, sex, and angina type categories. Initially, 4284/4415 (97%) patients were classified as intermediate-probability by the ESC-DF (PTP 15-85%); using the PROMISE-PTP, 50.2% of these patients were reclassified to the low PTP category (PTP < 15%). CONCLUSION: The ESC-DF PTP overestimate vastly the actual prevalence of CAD ≥ 50%. A new set of PTP, derived from results of non-invasive testing, may substantially reduce the need for non-invasive tests in stable chest pain.

    AB - AIMS: To update pretest probabilities (PTP) for obstructive coronary artery disease (CAD ≥ 50%) across age, sex, and clinical symptom strata, using coronary computed tomography angiography (CTA) in a large contemporary population of patients with stable chest pain referred to non-invasive testing. METHODS AND RESULTS: We included patients enrolled in the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial and randomized to CTA. Exclusively level III-certified readers, blinded to demographic and clinical data, assessed the prevalence of CAD ≥ 50% in a central core lab. After comparing the recent European Society of Cardiology-Diamond and Forrester PTP (ESC-DF) with the actual observed prevalence of CAD ≥ 50%, we created a new PTP set by replacing the ESC-DF PTP with the observed prevalence of CAD ≥ 50% across strata of age, sex, and type of angina. In 4415 patients (48.3% men; 60.5 ± 8.2 years; 78% atypical angina; 11% typical angina; 11% non-anginal chest pain), the observed prevalence of CAD ≥ 50% was 13.9%, only one-third of the average ESC-DF PTP (40.6; P < 0.001 for difference). The PTP in the new set ranged 2-48% and were consistently lower than the ESC-DF PTP across all age, sex, and angina type categories. Initially, 4284/4415 (97%) patients were classified as intermediate-probability by the ESC-DF (PTP 15-85%); using the PROMISE-PTP, 50.2% of these patients were reclassified to the low PTP category (PTP < 15%). CONCLUSION: The ESC-DF PTP overestimate vastly the actual prevalence of CAD ≥ 50%. A new set of PTP, derived from results of non-invasive testing, may substantially reduce the need for non-invasive tests in stable chest pain.

    KW - computed tomography angiography

    KW - coronary stenosis

    KW - Diamond and Forrester

    KW - obstructive coronary artery disease

    KW - stable chest pain

    UR - http://www.scopus.com/inward/record.url?scp=85067188521&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85067188521&partnerID=8YFLogxK

    U2 - 10.1093/ehjci/jey182

    DO - 10.1093/ehjci/jey182

    M3 - Article

    VL - 20

    SP - 574

    EP - 581

    JO - European Heart Journal Cardiovascular Imaging

    JF - European Heart Journal Cardiovascular Imaging

    SN - 2047-2404

    IS - 5

    ER -